TY  - GEN
AU  - Koh,Adrian
AU  - Lee,Won Ki
AU  - Chen,Lee-Jen
AU  - Chen,Shih-Jen
AU  - Hashad,Yehia
AU  - Kim,Hakyoung
AU  - Lai,Timothy Y
AU  - Pilz,Stefan
AU  - Ruamviboonsuk,Paisan
AU  - Tokaji,Erika
AU  - Weisberger,Annemarie
AU  - Lim,Tock H
TI  - EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy
SN  - 1539-2864
PY  - 2012///1128
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Choroid
KW  - blood supply
KW  - Choroid Diseases
KW  - diagnosis
KW  - Coloring Agents
KW  - Combined Modality Therapy
KW  - Double-Blind Method
KW  - Female
KW  - Fluorescein Angiography
KW  - Humans
KW  - Indocyanine Green
KW  - Intravitreal Injections
KW  - Male
KW  - Middle Aged
KW  - Photochemotherapy
KW  - Photosensitizing Agents
KW  - Polyps
KW  - Porphyrins
KW  - Ranibizumab
KW  - Treatment Outcome
KW  - Verteporfin
KW  - Visual Acuity
KW  - physiology
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/IAE.0b013e31824f91e8
ER  -